Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
01/2001
01/02/2001US6168776 Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
12/2000
12/27/2000EP1062217A1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
12/27/2000EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
12/27/2000CN1059909C Granular polybenzoxazine intermediate and its preparation method
12/26/2000US6166202 Benzophenoxazine dyes
12/26/2000US6166010 For combating animal pests
12/26/2000US6166009 For clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which c-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6165941 Substituted 2-phenylpyridines
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/20/2000EP1027341A4 High char yield benzoxazines
12/19/2000US6162805 Use of an NK-1 receptor antagonist and an SSRI for treating obesity
12/19/2000US6162425 A keratin-reducing agent without allergic and sensitizing reactions
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/12/2000US6160079 Activated arylamine-based polybenzoxazines
12/12/2000US6159902 Herbicides
12/07/2000WO2000072801A2 Alpha v integrin receptor antagonists
12/07/2000CA2373937A1 Alpha v integrin receptor antagonists
12/06/2000EP1056728A1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
12/06/2000CN1275912A Novel amide derivatives
12/05/2000US6156891 Production of pyridazine herbicides
12/05/2000US6156702 As herbicides
11/2000
11/30/2000WO2000071518A2 Heterocyclic analgesic compounds and their use
11/30/2000WO2000032583A9 Antitumor dibenzofluorene derivatives
11/30/2000CA2372887A1 Heterocyclic analgesic compounds and their use
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/28/2000US6153757 Metalloproteinase inhibitors and intermediates useful for their preparation
11/28/2000US6153624 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders
11/23/2000WO2000034237A3 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
11/22/2000CN1274361A Solution phase synthesis of oligonucleotides
11/21/2000US6150530 Amidation of amine with acid
11/21/2000US6150413 Treatment of dermatological, rheumatic, respiratory, cardiovascular, bone and ophthalmological disorders, as well as mammalian skin and hair conditions; 4-(4-(biphenyl-2-yl)but-3-en-1-ynyl)benzoic acid, for example
11/21/2000US6150372 Immunoinflammatory and autoimmune diseases; blocking intracellular signal transduction and activation of transcription factors; kinase inhibitors; antiarthritic, ischemic agents, multiple sclerosis, transplant rejection
11/21/2000US6150370 1,3-dinitrocyclic compound treats numerous diseases caused by undesired metalloprotease activity, such as tumor metastasis, osteoarthritis, rheumatoid arthritis, skin inflammation, ulcerations, and periodontitis
11/16/2000WO2000068212A1 Oxazoline or oxazine acetoacetate aqueous coating compositions
11/16/2000DE19920247A1 Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung Medicaments with an amount of compounds having a nitrogen-oxygen heterocycle as active ingredient and their use
11/15/2000EP1051403A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/15/2000CN1273244A Method for preparing cyclic thioamide compound
11/14/2000US6147210 Practical synthesis of benzoxazinones useful as HIV reverse transcriptase inhibitors
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066571A1 Cyclocarbamate derivatives as progesterone receptor modulators
11/09/2000WO2000066570A1 Cyclothiocarbamate derivatives as progesterone receptor modulators
11/09/2000WO2000066560A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
11/09/2000WO2000066551A1 Cyclic amide compounds, process for the preparation of the same and uses thereof
11/09/2000WO2000066165A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives
11/09/2000WO2000066094A2 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000WO2000032584A3 Nonsteroidal antiinflammatories
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371726A1 Cyclocarbamate derivatives as progesterone receptor modulators
11/09/2000CA2371651A1 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
11/09/2000CA2371618A1 Cyclic amide compounds, their production and use
11/09/2000CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000CA2369077A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives
11/08/2000EP1049684A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/07/2000US6143492 Compound useful as an optical probe; drug screening
11/02/2000WO2000064866A1 Diphenylurea derivatives
11/02/2000EP1048658A1 Alicyclic acylated heterocyclic derivatives
11/02/2000EP1047428A1 Pharmaceutically active morpholinol
11/02/2000EP1047410A1 Treatment of glc1a glaucoma with non-steroidal glucocorticoid antagonists
10/2000
10/31/2000US6140500 The new dyes are brighter and permeate cells faster than currently available red-emitting live-cell nucleic acid stains.
10/31/2000US6140499 4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
10/31/2000US6140326 Morpholinones as light stabilizers
10/26/2000WO2000063197A1 Hydroxamic acid derivative
10/26/2000WO2000063193A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
10/26/2000WO2000063192A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them
10/26/2000WO2000063191A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
10/26/2000WO2000063190A1 New compounds, their preparation and use
10/26/2000WO2000063189A1 Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
10/26/2000CA2370401A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them
10/25/2000EP1046627A2 Enantiopure reagents and process for the separation of enantiomers
10/24/2000US6136975 Method for producing trifluoroacetoacetic acid anilides
10/24/2000US6136970 Asymmetric dioxazine compounds and method for dyeing or printing fiber materials using the same
10/21/2000CA2305944A1 Process for separating enantiomers and enantiopur reagent
10/19/2000WO2000061649A1 Activated arylamine-based polybenzoxazines
10/18/2000EP1044194A1 Receptor with an affinity for compounds of the oxazoline class
10/18/2000CN1270584A Morpholinones as light stabilizers
10/17/2000US6133283 Mono- or polyenic carboxylic acid derivatives
10/17/2000US6133259 Diagnosis of alzheimer's disease
10/12/2000WO2000059884A1 Pharmaceutically active compounds and methods of use thereof
10/12/2000WO2000059868A1 Substituted aniline compounds
10/12/2000WO2000059866A1 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
10/12/2000WO2000059863A1 Disodium salts, monohydrates, and ethanol solvates
10/12/2000WO2000059480A1 Lyophilized solid dosage forms and methods of making
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
10/12/2000CA2368703A1 Substituted aniline compounds
10/12/2000CA2361734A1 Pharmaceutically active compounds and methods of use thereof
10/11/2000CN1057296C Morpholine and thiomorpholine tachykinin receptor antagonists and use
10/10/2000US6130331 Selective crystallization of stereoisomer
10/10/2000US6130214 Benzothiazin and benzoxazin derivatives; their preparation and uses
10/10/2000CA2028893C Morpholinols, their prepation and use
10/05/2000WO2000058292A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
10/05/2000WO2000058288A1 Pyridine-2,3-dicarboxylic acid diamides
10/05/2000CA2368451A1 Pyridine-2,3-dicarboxylic acid diamides
10/04/2000EP1041070A1 Process for preparing cyclic thioamides
09/2000
09/28/2000WO2000056760A1 Phenylalanine derivatives
09/28/2000WO2000039103B1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
09/28/2000CA2855415A1 Phenylalanine derivatives
09/28/2000CA2368733A1 Phenylalanine derivatives
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 112